entity

AD risk

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AD risk: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

1Hypotheses

4Analyses

0Outgoing

1Incoming

0Experiments

4Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (1)

Source	Relation	Type	Str
APOE4	risk_factor_for	gene	0.90

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Female microglia exhibit heightened complement gene expressi	0.610	neurodegeneration	Synaptic pruning by microglia in neurode

Mentioning Analyses (4)

Scientific analyses that reference this entity

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.591

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619

How does APOE4's beneficial immune function reconcile with its established role

neurodegeneration | 2026-04-12 | 1 hypotheses Top: 0.887

APOE4 targeting in neurodegeneration

neurodegeneration | 2026-04-02 | 4 hypotheses Top: 0.720

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (4)

Multi-agent debates referencing this entity

What are effective therapeutic strategies for targeting APOE4 in Alzheimer's dis

active · Rounds: 4 · Score: 0.82 · 2026-04-22

The abstract shows TYROBP deficiency is neuroprotective despite being required f

closed · Rounds: 4 · Score: 0.56 · 2026-04-15

The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mi

closed · Rounds: 4 · Score: 0.60 · 2026-04-15

How does APOE4's beneficial immune function reconcile with its established role

closed · Rounds: 4 · Score: 0.78 · 2026-04-12